Related Experiment Video
Updated: May 29, 2025

Real-time Analysis of Gut-brain Neural Communication: Cortex wide Calcium Dynamics in Response to Intestinal Glucose Stimulation
Published on: December 29, 2023
Characterization of Multidisciplinary Programs for Abdominal Pain-Related Disorders of Gut-Brain Interaction
Minna Rodrigo1, Bruno P Chumpitazi2, Erika A Chiappini3
1Division of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
Abstract:
Abdominal pain-related disorders of gut-brain interaction (DGBIs) are common and challenging conditions affecting many children and adolescents. Multidisciplinary programs represent one promising approach to these complex disorders. However, the composition of these programs and the therapies offered is unknown. We sought to better understand characteristics of these multidisciplinary programs. A survey was taken of pediatric gastroenterologists in the United States who practice in multidisciplinary DGBI programs to determine the characteristics of currently available programs. Fourteen pediatric gastroenterologists reported caring for children with DGBI in multidisciplinary programs distributed across all regions of the United States. The number of disciplines varied from 2 to 5, with the most common aside from pediatric gastroenterologists being dietitians (in 79% of programs) and behavioral psychologists (57%). The least common included physical therapists (14%). The number of therapies offered varied from 2 to 10 and included pharmacologic therapy (100%), dietary therapy (93%), and psychotherapy (86%), among others. The number of patients seen per clinic session varied (range: <3 to 6) across programs, and 6 programs (43%) assessed outcomes using validated questionnaires. Future studies may evaluate patient outcomes to identify an ideal pediatric DGBI multidisciplinary approach (eg, program composition and therapies offered).
More Related Videos
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Assessment of the Gastrointestinal System II: Health Perception Pattern
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Chronic Pancreatitis II: Collaborative Care
Assessment:

